Literature DB >> 3988274

Adenosquamous carcinoma of the lung: a clinical and pathologic study of seven cases.

P L Fitzgibbons, W H Kern.   

Abstract

Adenosquamous carcinoma is a rare, but pathologically distinct, form of lung cancer. Seven cases involving unequivocal squamous and glandular differentiation were studied. These cases accounted for 0.6 per cent of the 1,125 primary lung cancers examined at a metropolitan hospital during a 15-year period. The tumors measured from 1.3 to 5.5 cm in diameter. Five were peripheral, and two were associated with scars. Three of five resected specimens had regional lymph node metastases. Five patients had died of the disease within two years of diagnosis, and two were short-term survivors.

Entities:  

Mesh:

Year:  1985        PMID: 3988274     DOI: 10.1016/s0046-8177(85)80083-6

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  14 in total

Review 1.  The pivotal role of pathology in the management of lung cancer.

Authors:  Morgan R Davidson; Adi F Gazdar; Belinda E Clarke
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

2.  Is the incidence of primary adenocarcinoma of the lung increasing?

Authors:  C J Caldwell; C L Berry
Journal:  Virchows Arch       Date:  1996-12       Impact factor: 4.064

3.  Clinicopathological characteristics and prognosis of patients with adenosquamous lung carcinoma.

Authors:  Ye Guo; Lin Jia; Guo-Guang Shao; Hong-Wei Sun; Xing-Xing Wang; Guan-Jun Wang; Ke-Wei Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

4.  Prognostic value of combined platelet, fibrinogen, neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with lung adenosquamous cancer.

Authors:  Yu-Qian Wang; Qiong-Jie Zhi; Xin-Yue Wang; Dong-Sheng Yue; Kai Li; Ri-Cheng Jiang
Journal:  Oncol Lett       Date:  2017-07-24       Impact factor: 2.967

5.  Recent striking changes in histological differentiation and rate of human papillomavirus infection in squamous cell carcinoma of the lung in Okinawa, a subtropical island in southern Japan.

Authors:  J Miyagi; K Tsuhako; T Kinjo; T Iwamasa; T Hirayasu
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

6.  Human papillomavirus DNA in adenosquamous carcinoma of the lung.

Authors:  K Tsuhako; I Nakazato; T Hirayasu; H Sunakawa; T Iwamasa
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

7.  Clinical characteristics and prognosis of patients with lung adenosquamous carcinoma after surgical resection: results from two institutes.

Authors:  Lewei Zhu; Long Jiang; Jie Yang; Weiquan Gu; Jianxing He
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

8.  Clonal analysis of adenosquamous carcinoma of the lung.

Authors:  S Niho; T Yokose; T Kodama; Y Nishiwaki; K Mukai
Journal:  Jpn J Cancer Res       Date:  1999-11

9.  Clinical Outcomes of Different Generations of EGFR Tyrosine Kinase Inhibitors in Advanced Lung Adenosquamous Carcinoma.

Authors:  Minjuan Hu; Bo Zhang; Jianlin Xu; Shuyuan Wang; Yiming Zhao; Lele Zhang; Baohui Han
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

10.  A Nation-Wide Cancer Registry-Based Study of Adenosquamous Carcinoma in Taiwan.

Authors:  Yuan-Tzu Lan; Kuo-Hung Huang; Chien-An Liu; Ling-Chen Tai; Ming-Huang Chen; Yee Chao; Anna Fen-Yau Li; Shih-Hwa Chiou; Yi-Ming Shyr; Chew-Wun Wu; Wen-Liang Fang
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.